The conduct of clinical research in rare diseases is essential.
Despite their rarity, many fundamental advances in medicine have come from the study of rare diseases and these have benefited common diseases. In order to assure the future of this research, the training of the next generation of investigators in this field is important.
Who Should Attend: new investigators, trainees, junior faculty, and others interested in rare disease research methodology.
Attendees have the opportunity to:
2012 Conference Information
Resources from Past Conferences:
|RDCRN Home | Contact the Web Master | Accessibility | Disclaimer|
|The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and the Office for Rare Diseases Research (ORDR). NIH does not endorse or recommend any commercial products, processes, or services. The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Read Disclaimer >|